HO-EPCP CAS 62893-24-7 Pite > 98.0 (HPLC) Cefoperazone Sodyòm Entèmedyè
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-(-)-α-[[(4-Ethyl-2,3-Dioxo-1-Piperazinyl)carbonyl]amino]-4-Hydroxybenzeneacetic Acid (HO-EPCP) (CAS: 62893-24-7) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com
Non Chimik | (R)-(-)-α-[[(4-Ethyl-2,3-Dioxo-1-Piperazinyl)carbonyl]amino]-4-Hydroxybenzeneacetic Asid |
Sinonim | (R)-(-)-alfa-[[(4-Ethyl-2,3-Dioxo-1-Piperazinyl)carbonyl]amino]-4-Hydroxybenzeneacetic Asid;(R)-(-)-2-(4-Ethyl-2,3-Dioxopiperazine-1-Carboxamido)-2-(4-Hydroxyphenyl)acetic asid;(2R)-2-[(4-Ethyl-2,3-Dioxopiperazinyl)carbonylamino]-2-(4-Hydroxyphenyl)acetic Asid;HO-EPCP |
Enpurte | Cefoperazone enpurite 2 |
Nimewo CAS | 62893-24-7 |
Nimewo CAT | RF2482 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C15H17N3O6 |
Pwa molekilè | 335.32 |
Pwen k ap fonn | 203℃ (desanm) (lit.) |
Dansite | 1.456 g/mL |
Solibilite | Yon ti kras soluble nan metanol |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud blan oswa kristal |
Pite / Metòd analiz | >98.0% (HPLC) |
Pite / Metòd analiz | > 98.0% (titrasyon netralizasyon) |
Wotasyon espesifik [a]20/D | -90.0 ° a -80.0 ° (C = 1 nan MeOH) |
Pèt sou siye | <1.00% |
Enpurte total | <2.00% |
Enfrawouj Spectrum | Konfòm ak estrikti |
Spectre proton RMN | Konfòm ak estrikti |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè Cefoperazone (62893-19-0) ak Cefoperazone Sodyòm (CAS 62893-20-3) |
Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
Ki jan yo achte?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
15 ane eksperyans?Nou gen plis pase 15 ane eksperyans nan fabrike ak ekspòtasyon nan yon pakèt kalite entèmedyè pharmaceutique oswa pwodui chimik amann.
Mache prensipal yo?Vann nan mache domestik, Amerik di Nò, Ewòp, peyi Zend, Larisi, Kore di, Japonè, Ostrali, elatriye.
Avantaj?Ekselan bon jan kalite, pri abòdab, sèvis pwofesyonèl ak sipò teknik, livrezon rapid.
KaliteAsirans?Sistèm kontwòl kalite strik.Ekipman pwofesyonèl pou analiz yo enkli NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OSWA, KF, ROI, LOD, MP, Clarity, Solubility, tès limit mikwòb, elatriye.
Echantiyon yo?Pifò pwodwi bay echantiyon gratis pou evalyasyon kalite, pri anbake yo ta dwe peye pa kliyan yo.
Odit faktori?Odit faktori akeyi.Tanpri pran yon randevou davans.
MOQ?Pa gen MOQ.Ti lòd akseptab.
Tan livrezon? Si nan stock, twa jou livrezon garanti.
Transpò?Pa eksprime (FedEx, DHL), pa lè, pa lanmè.
Dokiman yo?Sèvis apre lavant: COA, MOA, ROS, MSDS, elatriye ka bay.
Sentèz Custom?Ka bay sèvis sentèz koutim pi byen anfòm bezwen rechèch ou yo.
Regleman Peman?Pwofòma fakti pral voye premye apre konfimasyon nan lòd, ki fèmen enfòmasyon bank nou an.Peman pa T/T (Telex Transfè), PayPal, Western Union, elatriye.
(R)-(-)-α-[[(4-Ethyl-2,3-Dioxo-1-Piperazinyl)carbonyl]amino]-4-Hydroxybenzeneacetic Acid (HO-EPCP) (CAS: 62893-24-7) se yon entèmedyè ki itilize pou prepare dérivés Cephalosporin ak aktivite kont bakteri Gram-pozitif ak Gram-negatif.HO-EPCP se yon entèmedyè Cefoperazone (62893-19-0) ak Cefoperazone Sodium (CAS 62893-20-3).Cefoperazone Sodium se yon twazyèm jenerasyon, antipseudomonalcephalosporin ki sanble ak piperacillin chimik ak mikrobyolojik.Li aktif kont anpil souch P. aeruginosa, endol-pozitif Proteus spp., Enterobacter spp., ak S. marcescens ki reziste tocefamandole.Li mwens aktif pase sefalotin kont bakteri Gram-pozitif ak mwens aktif pase cefamandoleakont pi fò nan Enterobacteriaceae yo.Menm jan ak Piperacillin, Cefoperazone idrolize pa anpil nan β-lactamas ki idrolize penisilin yo.Kontrèman ak Piperacillin, sepandan, li rezistan a kèk (men se pa tout) nan β-laktamaz ki idrolize Cephalosporins.Cefoperazone se elimine prensipalman nan kòlè a.Disfonksyon epatik ka afekte clearance li nan kò a.